COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications
- 28 April 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 68 (2), 251-252
- https://doi.org/10.1007/s12020-020-02325-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Molecular immune pathogenesis and diagnosis of COVID-19Journal of Pharmaceutical Analysis, 2020
- Pharmacokinetic/Pharmacodynamic Analysis of Daptomycin Against Staphylococcus aureus and Enterococcus faecium in Pediatric Patients by Monte Carlo SimulationThe Journal of Clinical Pharmacology, 2020
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe Lancet, 2020
- Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)Clinical Endocrinology, 2005
- Molecular mimicry of ACTH in SARS – implications for corticosteroid treatment and prophylaxisMedical Hypotheses, 2004